TVTX Annual Debt To Equity
1.88
-6.88-78.54%
31 December 2023
Summary:
As of January 22, 2025, TVTX annual debt to equity ratio is 1.88, with the most recent change of -6.88 (-78.54%) on December 31, 2023. During the last 3 years, it has risen by +0.86 (+84.31%). TVTX annual debt to equity is now -78.54% below its all-time high of 8.76, reached on December 31, 2022.TVTX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Quarterly Debt To Equity
-12.43
-37.39-149.80%
30 September 2024
Summary:
As of January 22, 2025, TVTX quarterly debt to equity ratio is -12.43, with the most recent change of -37.39 (-149.80%) on September 30, 2024. Over the past year, it has dropped by -14.31 (-761.17%). TVTX quarterly debt to equity is now -116.01% below its all-time high of 77.63, reached on June 30, 2014.TVTX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.5% | -761.2% |
| 3 y3 years | +84.3% | -241.9% |
| 5 y5 years | +176.5% | -241.9% |
TVTX Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | +150.7% | -149.8% | at low |
| 5 y | 5-year | -78.5% | +150.7% | -149.8% | at low |
| alltime | all time | -78.5% | +183.6% | -116.0% | at low |
Travere Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -12.43(-149.8%) |
| June 2024 | - | 24.96(+389.4%) |
| Mar 2024 | - | 5.10(+171.3%) |
| Dec 2023 | 1.88(-78.5%) | 1.88(+39.3%) |
| Sept 2023 | - | 1.35(-58.2%) |
| June 2023 | - | 3.23(+62.3%) |
| Mar 2023 | - | 1.99(-77.3%) |
| Dec 2022 | 8.76(+1068.0%) | 8.76(+134.9%) |
| Sept 2022 | - | 3.73(+56.1%) |
| June 2022 | - | 2.39(+32.8%) |
| Mar 2022 | - | 1.80(+140.0%) |
| Dec 2021 | 0.75(-26.5%) | 0.75(+2.7%) |
| Sept 2021 | - | 0.73(+10.6%) |
| June 2021 | - | 0.66(+10.0%) |
| Mar 2021 | - | 0.60(-41.2%) |
| Dec 2020 | 1.02(+9.7%) | 1.02(+43.7%) |
| Sept 2020 | - | 0.71(+7.6%) |
| June 2020 | - | 0.66(-28.3%) |
| Mar 2020 | - | 0.92(-1.1%) |
| Dec 2019 | 0.93(+36.8%) | 0.93(+13.4%) |
| Sept 2019 | - | 0.82(+13.9%) |
| June 2019 | - | 0.72(-6.5%) |
| Mar 2019 | - | 0.77(+13.2%) |
| Dec 2018 | 0.68(+353.3%) | 0.68(+1.5%) |
| Sept 2018 | - | 0.67(+318.8%) |
| June 2018 | - | 0.16(+6.7%) |
| Mar 2018 | - | 0.15(0.0%) |
| Dec 2017 | 0.15 | 0.15(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | 0.15(0.0%) |
| June 2017 | - | 0.15(0.0%) |
| Mar 2017 | - | 0.15(+7.1%) |
| Dec 2016 | 0.14(-6.7%) | 0.14(0.0%) |
| Sept 2016 | - | 0.14(0.0%) |
| June 2016 | - | 0.14(0.0%) |
| Mar 2016 | - | 0.14(-6.7%) |
| Dec 2015 | 0.15(-106.7%) | 0.15(0.0%) |
| Sept 2015 | - | 0.15(-73.2%) |
| June 2015 | - | 0.56(+12.0%) |
| Mar 2015 | - | 0.50(-122.2%) |
| Dec 2014 | -2.25(<-9900.0%) | -2.25(-72.5%) |
| Sept 2014 | - | -8.18(-110.5%) |
| June 2014 | - | 77.63(-8921.6%) |
| Mar 2014 | - | -0.88(<-9900.0%) |
| Dec 2013 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2013 | - | 0.00(0.0%) |
| June 2013 | - | 0.00(0.0%) |
| Mar 2013 | - | 0.00(-100.0%) |
| Dec 2012 | -0.26(-35.0%) | - |
| Nov 2012 | - | -0.39(0.0%) |
| Aug 2012 | - | -0.39(0.0%) |
| May 2012 | - | -0.39(-2.5%) |
| Feb 2012 | - | -0.40(0.0%) |
| Feb 2012 | -0.40(-2.4%) | - |
| Nov 2011 | - | -0.40(<-9900.0%) |
| Aug 2011 | - | 0.00(-100.0%) |
| Feb 2011 | -0.41 | -0.41 |
FAQ
- What is Travere Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Travere Therapeutics?
- What is Travere Therapeutics annual debt to equity year-on-year change?
- What is Travere Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Travere Therapeutics?
- What is Travere Therapeutics quarterly debt to equity year-on-year change?
What is Travere Therapeutics annual debt to equity ratio?
The current annual debt to equity of TVTX is 1.88
What is the all time high annual debt to equity for Travere Therapeutics?
Travere Therapeutics all-time high annual debt to equity ratio is 8.76
What is Travere Therapeutics annual debt to equity year-on-year change?
Over the past year, TVTX annual debt to equity ratio has changed by -6.88 (-78.54%)
What is Travere Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of TVTX is -12.43
What is the all time high quarterly debt to equity for Travere Therapeutics?
Travere Therapeutics all-time high quarterly debt to equity ratio is 77.63
What is Travere Therapeutics quarterly debt to equity year-on-year change?
Over the past year, TVTX quarterly debt to equity ratio has changed by -14.31 (-761.17%)